Genome-wide CRISPR screening plus DNA methylation validation identifies glioblastoma biomarkers for paclitaxel and carboplatin response.
Individually compressed, indexed chunks let genomic systems access selected fields while supporting unified formats and efficient exchange.
Automated annotation of genomic variants using pooled allele statistics reduces expert review time while maintaining accuracy across diverse populations.